Provided by Tiger Fintech (Singapore) Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

22.57
+0.08000.36%
Volume:690.75K
Turnover:15.62M
Market Cap:1.29B
PE:-9.65
High:23.43
Open:22.47
Low:21.79
Close:22.49
Loading ...

Structure Therapeutics initiated with a Buy at Stifel

TIPRANKS
·
08 Jan

Press Release: Septerna Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer

Dow Jones
·
06 Jan

BUZZ-Viking set to double in 'challenging' year for obesity drug developers

Reuters
·
01 Jan

Exicure to Acquire GPCR Therapeutics' US Unit

MT Newswires Live
·
27 Dec 2024

Exicure signs MOU with GPCR Therapeutics

TIPRANKS
·
27 Dec 2024

Press Release: Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

Dow Jones
·
27 Dec 2024

FACTBOX-Weight-loss drug developers line up to tap market worth $150 billion

Reuters
·
20 Dec 2024

Shares of Viking Therapeutics up 4.2%, Amgen up 1%

THOMSON REUTERS
·
20 Dec 2024

Weight Loss Drug Developers Rise After Novo Nordisk's Obesity Drug Cagrisema Achieves Lower Weight Loss Than Expected

THOMSON REUTERS
·
20 Dec 2024

BUZZ-Weight-loss drug developers gain after Novo's obesity drug underperforms in study

Reuters
·
20 Dec 2024

Weight Loss Drug Developers Rise Premarket After Novo Nordisk's Obesity Drug Cagrisema Achieves Lower Weight Loss Than Expected

THOMSON REUTERS
·
20 Dec 2024

Shares of Viking Therapeutics up 9.3%, Structure Therapeutics up 3.4%, Altimmune up 1.7% Premarket

THOMSON REUTERS
·
20 Dec 2024

Structure’s obesity pipeline value prop ‘unperturbed,’ says H.C. Wainwright

TIPRANKS
·
19 Dec 2024

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Piper Sandler

TIPRANKS
·
19 Dec 2024

Structure Therapeutics Price Target Maintained With a $91.00/Share by JMP Securities

Dow Jones
·
18 Dec 2024

Shares of Some Obesity Drug Developers Fall After Merck Signs up to $2 Bln Deal for Oral Obesity Drug

THOMSON REUTERS
·
18 Dec 2024